Alkermes' Corporate Presentation to be Webcast at the Deutsche Bank 38th Annual dbAccess Health Care
Alkermes' Corporate Presentation to be Webcast at the Deutsche Bank 38thAnnual dbAccess Health Care Conference
DUBLIN--(BUSINESS WIRE)-- Alkermes plc (NAS: ALKS) announced today that its corporate presentation will be webcast live at the Deutsche Bank 38th Annual dbAccess Health Care Conference on Wednesday, May 29, 2013, at 8:40 a.m. EDT (1:40 p.m. BST) from The Westin Boston Waterfront Hotel. The presentation may be accessed under the Investors tab on www.alkermes.com and will be archived for 14 days.
Alkermes plc is a fully integrated, global biopharmaceutical company that applies its scientific expertise and proprietary technologies to develop innovative medicines that improve patient outcomes. The company has a diversified portfolio of more than 20 commercial drug products and a substantial clinical pipeline of product candidates that address central nervous system (CNS) disorders such as addiction, schizophrenia and depression. Headquartered in Dublin, Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and manufacturing facilities in Gainesville, Georgia and Wilmington, Ohio. For more information, please visit Alkermes' website at www.alkermes.com.
Eva Stroynowski, +1 781 609 6823
KEYWORDS: United Kingdom Europe Ireland
The article Alkermes' Corporate Presentation to be Webcast at the Deutsche Bank 38th Annual dbAccess Health Care Conference originally appeared on Fool.com.Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.